Search the Archive
Archives by Date
NEJM — Recent Cardiology Articles- Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism August 31, 2026Catheter-directed thrombolysis led to a lower risk of death, recurrent pulmonary embolism, or cardiorespiratory decompensation or collapse at 7 days than anticoagulation alone in intermediate-high–risk acute pulmonary embolism.
- Immediate Ambulatory Electrocardiographic Monitoring in Syncope August 31, 2026Among patients with syncope that remained unexplained after evaluation in the ED, immediate initiation of 14-day ECG monitoring did not result in significantly fewer patient-reported syncope episodes at 1 year than standard care.
- Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation August 30, 2026In patients with severe aortic stenosis and coronary artery disease, a strategy of transcatheter aortic-valve implantation before percutaneous coronary intervention was noninferior to PCI before TAVI for major clinical events at 1 year.
- Tricuspid-Valve Intervention in Heart Failure August 30, 2026In patients with severe tricuspid regurgitation and heart failure, transcatheter tricuspid-valve repair plus medical therapy was superior to medical therapy alone in reducing hospitalizations for heart failure and deaths.
- Pulmonary Denervation for Heart Failure–Related Pulmonary Hypertension August 30, 2026In pulmonary hypertension associated with left heart disease and heart failure, pulmonary-artery denervation reduced clinical worsening and recurrent heart failure events as compared with guideline-directed medical therapy alone.
- Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism August 31, 2026
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
